rs121913598
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000530.8(MPZ):c.131C>T(p.Ser44Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S44C) has been classified as Uncertain significance.
Frequency
Consequence
NM_000530.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPZ | NM_000530.8 | c.131C>T | p.Ser44Phe | missense_variant | Exon 2 of 6 | ENST00000533357.5 | NP_000521.2 | |
MPZ | NM_001315491.2 | c.131C>T | p.Ser44Phe | missense_variant | Exon 2 of 6 | NP_001302420.1 | ||
MPZ | XM_017001321.3 | c.161C>T | p.Ser54Phe | missense_variant | Exon 2 of 6 | XP_016856810.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
- -
Charcot-Marie-Tooth disease Pathogenic:1Uncertain:1
- -
- -
Inborn genetic diseases Pathogenic:1
The p.S44F variant (also known as c.131C>T), located in coding exon 2 of the MPZ gene, results from a C to T substitution at nucleotide position 131. The serine at codon 44 is replaced by phenylalanine, an amino acid with highly dissimilar properties. This variant has been detected in multiple individuals with Charcot-Marie-Tooth disease and reportedly segregates with disease in multiple families (Marrosu MG et al. Neurology, 1998 May;50:1397-401; Benedetti S et al. Arch Neurol, 2010 Dec;67:1498-505; Gagliardi S et al. Br J Dermatol, 2017 07;177:284-286; Sanmaneechai O et al. Brain, 2015 Nov;138:3180-92; Lorefice L et al. Neurol Sci, 2017 Jun;38:1019-1025). Functional studies suggest that this variant may reduce cell adhesiveness in vitro (Lee YC et al. J Neurol, 2010 Oct;257:1661-8). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Charcot-Marie-Tooth disease, type I Pathogenic:1
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 44 of the MPZ protein (p.Ser44Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Charcot-Marie-Tooth disease (CMT) (PMID: 9595994, 21149811, 26310628, 27639257, 28286897). It has also been observed to segregate with disease in related individuals. Invitae Evidence Modeling of clinical and family history, age, sex, and reported ancestry of multiple individuals with this MPZ variant has been performed. This variant is expected to be pathogenic with a positive predictive value of at least 99%. This is a validated machine learning model that incorporates the clinical features of 11,906 individuals referred to our laboratory for MPZ testing. ClinVar contains an entry for this variant (Variation ID: 14185). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MPZ protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects MPZ function (PMID: 20461396). For these reasons, this variant has been classified as Pathogenic. -
Charcot-Marie-Tooth disease type 2I Pathogenic:1
- -
Charcot-Marie-Tooth disease type 1B Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at